Literature DB >> 32232884

Statins and glycaemic control in type 2 diabetes: Are bile acids relevant?

Daniel J Sansome1, Karen L Jones1, Michael Horowitz1, Christopher K Rayner1, Tongzhi Wu1,2.   

Abstract

Entities:  

Year:  2020        PMID： 32232884      PMCID： PMC7688544          DOI： 10.1111/bcp.14274

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  14 in total

Review 1.  Mechanism of glucose-lowering by metformin in type 2 diabetes: Role of bile acids.

Authors:  Daniel J Sansome; Cong Xie; Simon Veedfald; Michael Horowitz; Christopher K Rayner; Tongzhi Wu
Journal:  Diabetes Obes Metab       Date:  2019-10-07       Impact factor: 6.577

2.  Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice.

Authors:  Marleen Schonewille; Jan Freark de Boer; Laura Mele; Henk Wolters; Vincent W Bloks; Justina C Wolters; Jan A Kuivenhoven; Uwe J F Tietge; Gemma Brufau; Albert K Groen
Journal:  J Lipid Res       Date:  2016-06-16       Impact factor: 5.922

3.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

4.  Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

Authors:  Naveed Sattar; David Preiss; Heather M Murray; Paul Welsh; Brendan M Buckley; Anton J M de Craen; Sreenivasa Rao Kondapally Seshasai; John J McMurray; Dilys J Freeman; J Wouter Jukema; Peter W Macfarlane; Chris J Packard; David J Stott; Rudi G Westendorp; James Shepherd; Barry R Davis; Sara L Pressel; Roberto Marchioli; Rosa Maria Marfisi; Aldo P Maggioni; Luigi Tavazzi; Gianni Tognoni; John Kjekshus; Terje R Pedersen; Thomas J Cook; Antonio M Gotto; Michael B Clearfield; John R Downs; Haruo Nakamura; Yasuo Ohashi; Kyoichi Mizuno; Kausik K Ray; Ian Ford
Journal:  Lancet       Date:  2010-02-16       Impact factor: 79.321

5.  Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin.

Authors:  Marlene Wewalka; Mary-Elizabeth Patti; Corinne Barbato; Sander M Houten; Allison B Goldfine
Journal:  J Clin Endocrinol Metab       Date:  2014-01-16       Impact factor: 5.958

6.  Associations of statin use with glycaemic traits and incident type 2 diabetes.

Authors:  Fariba Ahmadizar; Carolina Ochoa-Rosales; Marija Glisic; Oscar H Franco; Taulant Muka; Bruno H Stricker
Journal:  Br J Clin Pharmacol       Date:  2019-03-18       Impact factor: 4.335

7.  Short-term effects of simvastatin on bile acid synthesis and bile lipid secretion in human subjects.

Authors:  P Loria; M Bertolotti; M T Cassinadri; M A Dilengite; M Bozzoli; F Carubbi; M Concari; M E Guicciardi; N Carulli
Journal:  Hepatology       Date:  1994-04       Impact factor: 17.425

8.  Lower intensified target LDL-c level of statin therapy results in a higher risk of incident diabetes: a meta-analysis.

Authors:  Rongrong Cai; Yang Yuan; Yi Zhou; Wenqing Xia; Pin Wang; Haixia Sun; Yue Yang; Rong Huang; Shaohua Wang
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

9.  Secondary failure of metformin monotherapy in clinical practice.

Authors:  Jonathan B Brown; Christopher Conner; Gregory A Nichols
Journal:  Diabetes Care       Date:  2009-12-29       Impact factor: 19.112

10.  Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases.

Authors:  Colin R Dormuth; Kristian B Filion; J Michael Paterson; Matthew T James; Gary F Teare; Colette B Raymond; Elham Rahme; Hala Tamim; Lorraine Lipscombe
Journal:  BMJ       Date:  2014-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.